Correlation Between Smithson Investment and Sartorius Stedim

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Smithson Investment and Sartorius Stedim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Smithson Investment and Sartorius Stedim into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Smithson Investment Trust and Sartorius Stedim Biotech, you can compare the effects of market volatilities on Smithson Investment and Sartorius Stedim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Smithson Investment with a short position of Sartorius Stedim. Check out your portfolio center. Please also check ongoing floating volatility patterns of Smithson Investment and Sartorius Stedim.

Diversification Opportunities for Smithson Investment and Sartorius Stedim

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Smithson and Sartorius is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Smithson Investment Trust and Sartorius Stedim Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sartorius Stedim Biotech and Smithson Investment is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Smithson Investment Trust are associated (or correlated) with Sartorius Stedim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sartorius Stedim Biotech has no effect on the direction of Smithson Investment i.e., Smithson Investment and Sartorius Stedim go up and down completely randomly.

Pair Corralation between Smithson Investment and Sartorius Stedim

Assuming the 90 days trading horizon Smithson Investment is expected to generate 10.38 times less return on investment than Sartorius Stedim. But when comparing it to its historical volatility, Smithson Investment Trust is 2.33 times less risky than Sartorius Stedim. It trades about 0.04 of its potential returns per unit of risk. Sartorius Stedim Biotech is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  18,113  in Sartorius Stedim Biotech on October 30, 2024 and sell it today you would earn a total of  2,817  from holding Sartorius Stedim Biotech or generate 15.55% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Smithson Investment Trust  vs.  Sartorius Stedim Biotech

 Performance 
       Timeline  
Smithson Investment Trust 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Smithson Investment Trust are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Smithson Investment may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Sartorius Stedim Biotech 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Sartorius Stedim unveiled solid returns over the last few months and may actually be approaching a breakup point.

Smithson Investment and Sartorius Stedim Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Smithson Investment and Sartorius Stedim

The main advantage of trading using opposite Smithson Investment and Sartorius Stedim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Smithson Investment position performs unexpectedly, Sartorius Stedim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sartorius Stedim will offset losses from the drop in Sartorius Stedim's long position.
The idea behind Smithson Investment Trust and Sartorius Stedim Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals